Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 67-72

  Credito, K L ^a   Lin, G ^a   Pankuch, G A ^a   Bajaksouzian, S ^a   Jacobs, M R ^a   Appelbaum, P C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CETHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; KETOLIDE; MACROLIDE; ROXITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; DOSE TIME EFFECT RELATION; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE; KETOLIDES; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; TIME FACTORS;

EID: 0035164494     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.67-72.2001     Document Type: Article

References (23)

1. Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA
2. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
3. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
4. Postantibiotic effect
5. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media
6. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children
7. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis
8. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases
9. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae
10. Efficacy of amoxicillin/clavulanate for acute otitis media: Relation to Streptococcus pneumoniae
11. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study
12. Comparative in-vitro activity of azithromycin and erythromycin against gram-positive cocci, Haemophilus influenzae and anaerobes
13. Haemophilus influenzae: Antibiotic susceptibility
14. The development of macrolides: Clarithromycin in perspective
15. In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite against Haemophilus influenzae
16. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and Moraxella catarrhalis by MIC determination and time-kill assay
17. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin and vancomycin by using time-kill methodology
18. Antipneumococcal activities of RP 59500 (quinupristin/dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies
19. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents
20. Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection
21. Susceptibility testing of Haemophilus influenzae - An international collaborative study in quality assessment
22. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis